MedPanel

Views & Analysis

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

R&D

Where do doctors see patients with rare diseases, how do they keep up with treatment advances and what can pharmaceutical companies do to help?

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.